3rd Quarter - Report

NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH for NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH

Firm
Client
Income
—
Expenses
$30,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Transportation TRA

Transportation of research animals Liaison with COVID-19 taskforce regarding research animal transportation issues

LobbyistCovered position, as disclosed
MATTHEW R BAILEY —
ROCCO PRAGLOWSKI —

Contacted: Veterans Affairs, Dept of (VA); Office of Science & Technology Policy (OSTP); Vice President of the U.S.; Commerce, Dept of (DOC); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Transportation, Dept of (DOT); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); U.S. Fish & Wildlife Service (USFWS); Treasury, Dept of

Animals ANI

Transportation of research animals H.R. 7268 "Humane Retirement Act" H.R. 2897 "AFTER Act" FY2021 Appropriations NIH, FDA, USDA, VA 21st Century Cures Act Implementation

LobbyistCovered position, as disclosed
MATTHEW R BAILEY —
ROCCO PRAGLOWSKI —

Contacted: Treasury, Dept of; Veterans Affairs, Dept of (VA); Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Commerce, Dept of (DOC); U.S. Fish & Wildlife Service (USFWS); Transportation, Dept of (DOT); Agriculture, Dept of (USDA); SENATE; Health & Human Services, Dept of (HHS); Vice President of the U.S.

Bills named: H.R. 7268 (116th), H.R. 2897 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.